RxDoctor Payments Data

Kelly Johnson, APRN

Family · David City, NENPI 1255652509

Payments from drug & device makers

$779in general payments, 2019–2025

Across 24 payments — averaging $32.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$251
  • Boehringer Ingelheim$127
  • Abbott$118
  • Amgen$81
  • Coloplast$73
  • Novo Nordisk$29
  • plus $100 from 5 others

What the payments were for

  • Food & beverage$779100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$779 in reported general payments places this provider in the 70th percentile of 809 family providers in Nebraska.

See all family providers in Nebraska

Medicare billing

Part B allowed, 2024
$65,327
Medicare patients
492
Services billed
742

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban153$135,621
XareltoRivaroxaban195$128,657
JardianceEmpagliflozin86$73,056
FarxigaDapagliflozin Propanediol110$67,202
OzempicSemaglutide49$52,028
EntrestoSacubitril/Valsartan47$32,855
TrulicityDulaglutide20$21,238
Repatha SureclickEvolocumab11$10,448
Praluent PenAlirocumab14$6,767
Ezetimibe164$4,706
NexletolBempedoic Acid11$4,367
Atorvastatin Calcium328$3,914
Metoprolol Succinate307$3,641
Ranolazine ErRanolazine37$2,610
Nebivolol Hcl43$2,152

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonXarelto$13$128,657195 claims
Boehringer IngelheimJardiance$127$73,05686 claims
Novo NordiskOzempic$29$52,02849 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 809 family providers in Nebraska.

Other family in David City

See the full list for Nebraska

Where these figures come from

Is this you, or does something look wrong? →